Skip to main content

Organ Rejection Transplants clinical trials at UCSF

1 in progress, 0 open to eligible people

Showing trials for
  • ExoFlo in Abdominal Solid Organ Transplant Patients

    Sorry, not accepting new patients

    This Expanded Access Protocol will provide access to the IMP ExoFlo for patients who have severe or life-threatening abdominal solid organ transplant rejection or who are evaluated and determined to be at high risk of progression to severe or life-threatening condition related to rejection of an abdominal solid organ transplant, at risk of worsening allograft function, or at risk of complications from current immunosuppressive therapeutic regimens.

    San Francisco, California and other locations

Last updated: